Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > GLPG Galapagos > Detailed Quotes

GLPG Galapagos

42.640
+0.370+0.88%
Close 09/30 16:00 ET
42.6400.0000.00%
Post Mkt Price 09/30 16:00 ET
High
43.160
Open
42.500
Turnover
6.55M
Low
42.490
Pre Close
42.270
Volume
153.49K
Market Cap
2.81B
P/E(TTM)
Loss
52wk High
72.110
Shares
65.84M
P/E(Static)
Loss
52wk Low
41.650
Float Cap
1.73B
Bid/Ask %
33.33%
Historical High
274.030
Shs Float
40.51M
Volume Ratio
1.10
Historical Low
4.700
Dividend TTM
--
Div Yield TTM
--
P/B
1.01
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.38%
Amplitude
1.59%
Avg Price
42.703
Lot Size
1
Float Cap
1.73B
Bid/Ask %
33.33%
Historical High
274.030
Shs Float
40.51M
Volume Ratio
1.10
Historical Low
4.700
Dividend TTM
--
P/B
1.01
Dividend LFY
--
Turnover Ratio
0.38%
Amplitude
1.59%
Avg Price
42.703
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
CEO: Mr. Onno van de Stolpe
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...